European Pharmaceutical ReviewBristol's Opdivo found effective in kidney cancerReutersJuly 20 Bristol-Myers Squibb Co said a late-stage trial testing Opdivo was stopped early after it was found beneficial in patients with the most common form of kidney cancer. An independent data committee recommended the trial be stopped, after it ...CheckMate -025, a Pivotal Phase III Opdivo (nivolumab) Renal Cell Cancer Trial ...MarketWatchUPDATED: Bristol-Myers flags early success for PhIII Opdivo study in kidney ...FierceBiotechBristol-Myers : Late-stage Opdivo RCC Trial CheckMate -025 Stopped EarlyRTT NewsAJMC.com Managed Markets Network -Scleroderma News -London South Eastall 11 news articles »
Bristol's Opdivo found effective in kidney cancer
Rating: 4.5
Diposkan Oleh: Unknown
